📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Should deep-sequenced amplicons become the new gold-standard for analysing malaria drug clinical trials? (2021)

First Author: Jones S

Attributed to: Improving the design and analysis of drug efficacy/effectiveness studies in malaria and in selected neglected tropical diseases (NTDs). funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.23.436602

Publication URI: http://dx.doi.org/10.1101/2021.03.23.436602

Type: Preprint